| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
R97 |
Abnormal tumor markers |
ICD10CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
795.82 |
Elevated cancer antigen 125 [CA 125] |
ICD9CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
R97.1 |
Elevated cancer antigen 125 [CA 125] |
ICD10CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
795.81 |
Elevated carcinoembryonic antigen [CEA] |
ICD9CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
R97.0 |
Elevated carcinoembryonic antigen [CEA] |
ICD10CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
R97.2 |
Elevated prostate specific antigen [PSA] |
ICD10CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
R97.20 |
Elevated prostate specific antigen [PSA] |
ICD10CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
795.89 |
Other abnormal tumor markers |
ICD9CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
R97.8 |
Other abnormal tumor markers |
ICD10CM |
MGI |
| 795.8 |
Abnormal tumor markers |
795-795.99 |
Both |
symptoms |
R97.21 |
Rising PSA following treatment for malignant neoplasm of prostate |
ICD10CM |
MGI |
